pharma · hidradenitis suppurativa (HS) · Hidradenitis Suppurativa · MLTX
MoonLake Immunotherapeutics
MoonLake Immunotherapeutics trial registry — 19 ClinicalTrials.gov studies with program phase, status, and indication context.
Dorfstrasse, 29, Zug 6300, CH HQ
2021 Founded
133 Employees
Public company Type
MLTX · NYSE Ticker
Company details
- Status
- Public
- HQ
- Dorfstrasse, 29, Zug 6300, CH
- Founded
- 2021
- Employees
- 133
- Programs
- 13
- Drugs
- 11
- Patents
- 0
MoonLake Immunotherapeutics clinical trials
Registry index of 19 ClinicalTrials.gov studies linked to MoonLake Immunotherapeutics programs — each row shows trial ID, program name, phase, status, and indication.
MoonLake Immunotherapeutics trial registry — 19 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for MoonLake Immunotherapeutics.
-
M1095-PSA-302 — Phase 3
Clinical update -
M1095-PSA-301 — Phase 3
Clinical update -
M1095-HS-302 — Phase 3
Clinical update -
M1095-HS-301 — Phase 3
Clinical update -
68Ga-FAPI-46, Sonelokimab — Phase 2
Clinical update -
Sonelokimab — Phase 1
Clinical update -
Sonelokimab — Phase 3
Clinical update -
Sonelokimab — Phase 2
Clinical update